Respiratory pathology Flashcards

1
Q

What is COPD?

A
  • progressive airway obstruction which does not change markedly over several months
  • characterised by persistant airflow obstruction
  • poorly reversible + usually progressive
  • obstructive element important; it’s obstruction to airflow which causes the disabling symptoms of breathlessness + impairs QoL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The term COPD has replaced the old terms chronic bronchitis and emphysema. What are these two things?

A
  • chronic bronchitis - defined clinically as ‘cough productive of sputum for 3 consecutive months for 2 consecutive years which cannot be attributed to other cardiac or pulmonary disease’
  • emphysema - defined pathologically as ‘permanent dilatation of airways distal to terminal bronchiole’. It is an ‘apparent’ dilatation of airspaces but is, in fact, due to destruction of alveolar walls

Most COPD patients have features of both chronic bronchitis + emphysema since they share a common trigger (smoking).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The airflow obstruction is the result of damage to both small conducting airways and alveoli. What factor almost always causes the damage?

A
  • tobacco smoking
  • other important factors: occupation eg. those associated w/ dust (mining), a1-antitrypsin deficiency
  • important to realise that only a minority of smokers develop COPD
  • reason for this unknown, but evidence suggests that inflammatory response is amplified in susceptible people
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

All the airways throughout the respiratory tract are damaged by smoking, although the specific effects at each level are different.

What happens at the bronchi with smoking?

A
  • hyplerplasia of mucus-producing glands in submucosa
  • hyperplasia of goblet cells on surface epithelium
  • leads to increased sputum production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What happens at the small airways with smoking?

A
  • chronic inflammation
  • healing by fibrosis
  • stenosis of the airways
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What effect does smoking have at the respiratory bronchioles?

A

Destruction of the walls with loss of elastic tissue but without significant fibrosis -> airway dilatation -> emphysema

Destruction has 2 major effects:

  1. loss of pulmonary SA for gas exchange -> hypoxia
  2. loss of elastic tissue of terminal airways -> loss of natural recoil of lungs -> contributes to reduction in airflow on expiration ie. airflow obstruction

Remember: in normal lungs the elastic recoil acts to collapse the lung and is opposed by negative intrapleural pressure which maintains lung expansion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the protease/antiprotease hypothesis?

A
  • may account for lung destruction in emphysema
  • smoking causes inc # of activated neutrophils in lung
  • where they release protease enzymes (elastase)
  • in adddition, smoking inhibits the lung’s natural protease inhibitor enzymes eg. a1-antitrypsin
  • therefore, large amounts of active elastase enters lung interstitium
  • binds to + degrades elastin
  • results in destruction + enlargement of distal airspaces
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The clinical effects of smoking vary between individuals, some may develop smoker’s cough + inc sputum production yet remain relatively free from obstruction + breathlessness and vice versa.

What is the clinical presentation of COPD?

A
  • symptoms have an insidious onset
  • earliest symptom in natural history of COPD = cough + sputum
    • reflects involvement of larger airways
  • susceptible individuals continue to smoke? -> small airways become inc obstructed -> sudden SoBoe
  • advanced disease -> breathlessness occurs upon minimal exertion and then at rest
  • death in COPD is usually from bronchopneumonia, resp or heart failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the role of spirometry in the diagnosis of COPD?

A

spirometry confirms diagnosis of COPD by demonstrating airflow obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe an acute exacerbation of COPD

A
  • sudden, sustained worsening in pt’s symptoms
  • beyond their normal day-day variation
  • eg. worsening breathless + cough, inc sputum
  • may require a change in treatment
  • infection (bacterial or viral) = most common cause of an acute exacerbation of COPD
  • other less common causes incl pneumothorax, PE, LVF, lung carcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is an infective exacerbation of COPD different from pneumonia?

A
  • the airways are focus of infection in an infective exacerbation
  • in pneumonia, infection is centred on the alveoli
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

COPD is the most common cause of cor pulmonale (right heart failure due to lung disease).

What other changes/complications can COPD induce in the pulmonary circulation?

A
  • emphysema -> loss of pulmonary arterioles + capillaries
  • chronic hypoxia -> pulmonary artery vasoconstriction
  • chronic hypoxia -> inc EPO prod by kidney -> inc RBC prod -> inc blood viscosity

All these changes contribute to gradual development of pulmonary hypertension.

Initially, the right ventricle undergoes compensatory RV hypertrophy but eventually the RV decompensates and right heart failure ensues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is pneumonia?

A
  • inflammation of the lung parenchyma (ie alveolar spaces)
  • due to an infective agent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the pathological classification of pneumonia?

A

lobar vs bronchopneumonia

  • BRONCHOPNEUMONIA
    • widespread patchy inflammation centred on airways
    • often bilateral
    • patchy areas of consolidation
    • bronchi containing acute inflammatory exudate
    • also upper lobe emphysema
  • LOBAR PNEUMONIA
    • diffuse inflammation affecting an entire lobe/lobes
    • photo - entire lobe, paler than other
    • consolidation due to accum of acute inflammatory exudate within alveoli
    • abrupt demarcation at interlobar fissure

This classification largely was based on macroscopic exam of lungs at autopsy in pts w/ florid pneumonias in a pre-antibiotic era. Problem - difficult to apply in most cases as patterns overlap + classical picture is extremely blurred by modern day abx therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does consolidation refer to?

A
  • on CXR - refers to replacement of air in alveoli by fluid or other material, with preservation of underlying alveolar architecture
  • in case of pneumonia, air is replaced by acute inflammatory exudate
  • there is no destruction of underlying architecture
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

A more clinically relevant classification is based on circumstances surrounding development of pneumonia. These subdivisions are more useful bc each type of pneumonia is associated w/ a particular group of likely pathogens.

Pts can be easily placed into a category + the relevant antimicrobial therapy can be prescribed.

What organisms cause community-acquired pneumonia?

A
  • strep. pneumoniae (pneumococcus) single most common cause (-> mild + severe pneumonia)
  • influenza + other viruses
  • chlamydia pneumoniae/psittaci
  • mycoplasma pneumoniae
  • legionella pneumonia (-> severe pneumonia)
  • haemophilus influenzae
  • s. aureus (-> severe pneumonia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the CURB-65 severity score for community-acquired pneumonia?

A

CURB-65 score used to assess the severity of CAP, it’s been validated for predicting mortality

each risk factor scores one point, for a max score of 5:

  • Confusion of new onset (AMT ≤8)
  • Urea >7mmol/L
  • Resp rate ≥30
  • BP <90 systolic or ≤60 diastolic
  • 65 years or older

The risk of death increases as the score increases - helps in deciding which pts require hospital admission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Hospital-acquired pneumonia occurs 2 days or more after admission to hospital.

What organisms are responsible for this?

A

Gram negative bacteria are responsible for ~60% of cases

  • Klebsiella
  • E. Coli
  • Pseudomonas

S. aureus and S. pneumoniae are also important causes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is aspiration pneumonia due to?

A
  • pneumonia due to aspiration
  • particularly a risk in:
    • intoxicated patients
    • acute stroke patients w/ impaired swallowing
    • septic patients w/ reduced consciousness

Aspiration pneumonias are often mixed infections including anaerobes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Conventional respiratory pathogens are still common but generally the infection is more severe, with pneumonia in the immunocompromised.

In addition, they are susceptible to less virulent organisms, such as?

A
  • fungi eg. pneumocystitis, candida, aspergillus
  • mycobacterial infection eg. M. tuberculosis or atypical mycobacteria
  • viruses eg. CMV, HSV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What happens in diffuse parenchymal lung diseases (=intersitital lung diseases)?

A
  • large group of conditions characterised by inflammation centres on the interstitium of alveolar walls
  • interstitium becomes expanded by inflammatory cell infiltrate (‘pneumonitis’ or ‘alveolitis’)
  • impairs gas exchange + causes breathlessness
  • episodes of alveolitis may be followed by complete regeneration without residual damage to alveoli
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

With interstitial lung disease where most inflammation may completely regenerate, sometime the inflammation is followed by repair with scarring.

What happens here?

A
  • macrophages release fibrogenic cytokines
  • stimulate fibroblasts in interstitium
  • secrete collagen (scar tissue)
  • thickened alveolar walls are ineffective at gas exchange
  • resulting in worsening breathlessnes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is meant by the terms ‘pneumonitis’, ‘alveolitis’ and ‘pneumonia’?

A
  • pneumonitis - inflammation of lung parenchyma ie. the alveoli (alveolitis is an alternative name) - usually due to non-infective causes. Inflammation is limited to interstitium.
  • pneumonia - inflammation of the lung parenchyma due to an infective agent - characterised by consolidation - acute inflammatory exudate filling alveolar spaces.
24
Q

There are 200+ DPLDs. They can be caused by anything which sets up chronic inflammation within the interstitial space of alveolar walls.

What are the 5 basic categories that can divide up the causes?

A
  • unknown cause (idiopathic intersitital lung disease)
  • pneumoconioses (inhaled inorganic/mineral dusts), eg. coal dust, silica, asbestos
  • extrinsic allergic alveolitis (inhaled organic) eg. bird fancier lung, farmer’s lung
  • side-effects of treatment - eg. therapeutic chest radiation, certain drugs (amiodarone)
  • multisystem diseases involving lung eg. sarcoid, SLE, RA, scleroderma
25
Q

What are signs and symptoms of interstitial lung disease?

A
  • dry cough, progressive dyspnoea, wheeze, chest pain
  • clubbing
  • reduced chest wall expansion bilaterally
  • dull percussion note
  • inc vocal resonance
  • bronchial breathing
  • fine, late-pan inspiratory crackles

Also depends on the underlying cause

26
Q

How is interstitial lung disease diagnosed?

A
  • history + exam
    • a meticulous history vital in identifying cause
  • CXR -> reticulation
  • spriometry -> restrictive
  • high-res CT -> reticulation
  • lung biopsy sometimes necessary
27
Q

What is the management of intersitital lung disease?

A
  • oxygen
  • pulmonary rehabilitation
  • corticosteroids, cycophosphamide, azothiaprine
  • lung transplantation
28
Q

How do DLPDs such as pulmonary fibrosis cause cor pulmonale (right heart failure due to lung disease)?

A
  • important cause of cor pulmonale
  • fibrosis of lung tissue obliterates pulm arterioles + caps
  • -> gradual development of pulmonary hypertension
  • right ventricule undergoes compensatory right ventricular hypertrophy
  • eventually, right ventricle decompensates
  • right heart failure ensues
29
Q

Lung cancer is the 2nd most common cance rin the UK w/ a peak incidence in the 50-60yo age group. It’s the most common cause of cancer death in both men + women - bc of poor prognosis (<10% of pts remain alive 5 yrs from diagnosis).

What are the causes of lung cancer?

A
  • 80-90% lung carcinomas attributed to cig smoking
  • lung cancer only develops in ~10% heavy smokers
  • 10-20% lung cancers occur in non-smokers, causes:
    • industrial hazards eg. asbestos, arsenic, chromium, radiation
    • env exposure eg. radon gas (cornwall)
    • genetic factors eg. EGFR (epidermal growth factor receptor) gene mutations
30
Q

The majority of lung cancers are carcinomas. They can be subdivided into 4 main groups + a misc category.

What are the different types/groups?

A
  • adenocarcinoma (40%)
  • squamous cell carcinoma (25%)
  • small cell carcinoma (15%)
  • others (eg. carcinoid, large cell neuroendocrine carcinoma etc)

also, don’t forget that lung is most common site of metastatic tumour (both carcinomas and sarcomas arising anywhere in the body may spread to the lungs)

31
Q

How does squamous cell carcinoma arise in the lung?

A
  • strong association w/ smoking
  • tends to arise in larger airways near hilum
  • graded as: well, moderately or poorly differentiated
  • well-defined ‘metaplasia-dysplasia-carcinoma’ sequence
32
Q

What are characteristics of adenocarcinoma?

A
  • increaseing in incidence (uknown reason)
  • most common type of lung cancer in non-smokers
  • associated w/ mutations in EGFR gene
  • tends to arise in peripheral smaller airways
  • graded as: well, moderately or poorly differentiated
  • premalignant lesion is called atypical adenomatous hyperplasia (equiv to dysplasia)
  • it is asymptomatic
33
Q

What are characteristics of small cell carcinoma?

A
  • strongest association w/ smoking
  • usually arise in central location
  • highly aggressive tumour, notorious for rapid growth + early spread
  • not graded (by definition, small cell carcinoma = high grade)
  • no recognised precursor (premalignant) lesion
34
Q

What are large cell carcinomas?

A
  • undifferentiated carcinomas
  • cannot be otherwise categories
  • lack morphological features of other forms of lung cancer
35
Q

In recent years there have been several important advances in understanding of the genomics of lung cancer. Some genetic mutations are targets for new therapies.

Use tyrosine kinase inhibitors as an example of this

A
  • EGFR is a transmembrane tyrosine kinase that is mutated in between 10-50% of non-small cell carcinomas
  • certain EGFR mutations are associated w/ response to tyrosine kinase inhibitors eg. gefitinib + erlotinib
  • another genomic alteration seein in approx 2-5% of lung cancers is an inversion in the short arm of chromosome 2 -> results in fusion of EML4 gene w/ ALK gene -> results in EML4-ALK fusion tyrosine kinase - tumours with this mutation are associated w/ response to the TKI crizotinib
36
Q

How is immunotherapy in targeting genetic mutations for lung cancer?

A
  • immune checkpoints affect immune system functioning
  • can be stimulatory or inhibitory
  • tumours can use checkpoints to protect themselves from immune attacks
  • PD-L1 is a key regulator of T cell function
    • binds to PD1 on T cells + inhibits their activity
    • PD-L1 expressed by some cancer cells
    • enables them to inhibit T cells that might attack them
  • PD1 and PDL1 inhibitors (monoclonal abs) eg pembrolizumab have been developed for non-small cell lung cancer
  • the antibodies bind to either PD-1 or PD-L1 + therefore blocks the interaction
  • therefore, immune system able to mount response to tumour cells + kill them
37
Q

Obtaining a histological/cytological diagnosis of malignancy is important prior to tx.

One reason for this is bc certain non-malignant processes (benign tumours, certain infection) can result in a mass lesion in the lung. Also, important to know the histological type of cancer that the patient has for management purposes + prognosis.

What investigations are best for the following?

  • central lesions
  • peripheral lesions
A
  • central lesions (ie near hilum) -> bronchoscopy sampling
    • biopsy (histology) and/or washings, brushings (cytology)
  • peripheral lesions -> CT-guided sampling
    • biopsy (histology) and/or FNA (cytology)
38
Q

How is lung cancer staged?

A
  • both small + non-small cell carcinoma staged using TNM
  • imaging has a very important role in staging lung cancer:
    • CT good for T (tumour) staging - less sensitive for detection of involved lymph nodes + distant mets
    • PET or PET-CT enables more accurate staging of N (nodes) + M (mets) prior to surgery
39
Q

What are local symptoms and signs of lung cancer?

A
  • cough (involvement of central airways) - most common initial presenting symptoms
  • haemoptysis (bleeding from tumour)
  • stridor/wheeze (large airway obstruction)
  • hoarse voice (invasion of left recurrent laryngeal nerve)
  • breathlessness (large airway obstruction and/or development of associated pleural effusion)
  • chest wall pain (chest wall involvement)
  • non-resolving pneumonia (tumours may partially obstruct airways leading to infection)
40
Q

What is the link with SVC obstruction and lung cancer?

A
  • obstruction of SVC usually due to right-sided lung tumour (often small cell carcinoma)
  • causes increased venous pressure
  • results in interstitial oedema + retrograde collateral flow
  • collateral venous return to heart from upper half of body is through azygos venous system, internal mammary venous system and long thoracic venous system
  • despite collateral pathways, venous pressure is almost always elevated
  • most common symptoms = SoB, facial swelling, head fullness, cough, arm swelling, chest pain, dysphagia, hoarseness, stridor
  • SVC obstruction = oncological emergency bc may lead to laryngeal oedema, cerebral oedema or decreased CO
41
Q

What is Pancoast’s tumour?

A
  • in apex of lung
  • involves 8th cervical + 1st and 2nd thoracic nerves
  • may manifest as Pancoast’s syndrome
    • shoulder pain radiating in an ulnar distribution down arm
  • or Horner’s syndrome
42
Q

What is Horner’s syndrome characterised by?

A
  • endopthalmos (eyeball depression)
  • ptosis (droop) of upper eyelid
  • miosis (pupil constriction)
  • anhidrosis (absence of sweating)

Many causes of Horner’s syndrome, of which Pancoast’s tumour is one. Is it is due to sympathetic nerve infiltration by tumour, particularly T1

43
Q

What are systemic symptoms of lung cancer?

A
  • refer to general effects of tumour mass on body
  • giving rise to non-specific constitutional symptoms
  • weight loss, lethargy, vague sense of ill health
44
Q

What are distant mets?

A
  • lung cancer may metastasise to any organ of body
  • produce symptoms that may form the presenting complaint
  • bone, liver, CNS
45
Q

Hypercalcaemia is a paraneoplastic manifestation of lung cancer. How is this?

A
  • more common w/ squamous cell carcinomas
  • as a paraneoplastic effect, is is due to production of a PTH-related peptide (PTH-rP) by tumour cells
  • -> release of calcium from bone

remember that hypercalcaemia in the setting of lung cancer is usually due to bony metastases (not a paraneoplastic syndrome)

46
Q

How does SIADH (syndrome of inappropriate ADH secretion) result as a paraneoplastic manifestation of lung cancer?

A
  • mainly seen w/ small cell carcinomas
  • in half cases there is in inappt secretion of ADH by tumour cells
  • in other half, there is inappt secretion of ADH from posterior pituitary bc of altered/defective chemoreceptor control
  • the inappt secretion of ADH -> inappt water reabsorption
  • –> low serum [Na+], low serum osmolality + overhydration
47
Q

How is ectopic ACTH secretion from tumour cells a paraneoplastic manifestation of lung cancer?

A
  • typically associated w/ small cell carcinomas
  • inappt secretion of ACTH by tumour cells
  • leads to bilateral adrenal cortical hyperplasia
  • and secretion of inappt amounts of cortisol
  • chief manifestations: thirst + polyuria
  • typical features of Cushing’s syndrome rarely seen, as death often occurs before features fully develop
48
Q

LEMS is another paraneoplastic manifestation of lung cancer. What is lambert eaton myasthenic syndrome (LEMS)?

A
  • typically associated w/ small cell carcinomas
  • autoantibodies block voltage gated calcium channels in presynaptic membrane
  • thereby blocking ACh release
  • in about 50% cases, underlying malignancy present (ie. paraneoplastic syndrome)
  • it’s thought that stimulus for autoantibody formation in these cases may be expression of same calcium channel in tumour cells
49
Q

Lung carcinomas are divided into two management groups.

How is small cell lung carcinoma (SCLC) managed?

A
  • highly aggressive tumours in which extensive mets are usually already present at time of diagnosis
  • so surgery has little role in management of SCLC
  • initially, tumours are responsive to chemotherapy
  • however, after a period of time (few months), tumours become chemoresistant + progresses rapidly
50
Q

How is non-small cell lung carcinoma (NSCLC) managed?

A
  • group encompasses other histological type (eg. squamous carcinoma, adenocarcinoma etc)
  • the tumours generally managed in similar way, depending on stage + other factors
  • surgery is a possiblity if disease is low stage: chemotherapy is also used
51
Q

What is mesothelioma?

A
  • malignant tumour of pleura
  • associated w/ asbestos exposure
  • mesothelium = cell lining of pleura
  • usually long latency period (in order of 40yrs) between exposure + development of tumour
52
Q

What is the typical presentation of mesothelioma?

A
  • men aged 60+
  • breathlessness
  • chest pain
    • pleural effusion

Occupational history super important for diagnosis.

53
Q

How is the diagnosis made for mesothelioma?

A
  • cytological examination of pleural fluid
  • or on histological examination of a pleural biopsy
  • tumour spreads extensively within chest wall, encasing entire lung
  • mesothelioma is not graded (by definition it is highly aggressive)
  • mesothelioma has a dismal prognosis - mean survival is around 18 months from diagnosis
54
Q

Apart from mesothelioma, another important asbestos-related disease is lung cancer. How is this so?

A
  • asbestos alone increases risk of lung cancer
  • smokers who are also exposed to asbestos have risk of developing lung cancer that is greater than the individual risks from asbestos and smoking adding together (ie. the risk factors are synergistic)
55
Q

What is asbestosis?

A
  • one type of diffuse parenchymal lung disease
  • diffuse fibrosis of lung parenchyma (ie. lung fibrosis) due to asbestos
  • v high levels of asbestos exposure required to cause lung fibrosis + so asbestosis is rare
  • in contrast, the pleural changes caused by asbestos occur at lower levels of exposure and so are much more common
  • pts w/ asbestosis usually present w/ gradually worsening dyspnoea which terminates in chronic respiratory failure